These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 32097175)

  • 1. Hepatic manifestations of cystic fibrosis.
    Dana J; Girard M; Debray D
    Curr Opin Gastroenterol; 2020 May; 36(3):192-198. PubMed ID: 32097175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver disease in patients with cystic fibrosis.
    Kamal N; Surana P; Koh C
    Curr Opin Gastroenterol; 2018 May; 34(3):146-151. PubMed ID: 29438119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of liver disease and portal hypertension in cystic fibrosis: a review.
    Colombo C; Lanfranchi C; Tosetti G; Corti F; Primignani M
    Expert Rev Respir Med; 2024 May; 18(5):269-281. PubMed ID: 38962827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cystic fibrosis associated with liver disease].
    Debray D
    Arch Pediatr; 2012 May; 19 Suppl 1():S23-6. PubMed ID: 22682485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cystic fibrosis-related liver disease: Clinical presentations, diagnostic and monitoring approaches in the era of CFTR modulator therapies.
    Dana J; Debray D; Beaufrère A; Hillaire S; Fabre M; Reinhold C; Baumert TF; Berteloot L; Vilgrain V
    J Hepatol; 2022 Feb; 76(2):420-434. PubMed ID: 34678405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cystic Fibrosis-Associated Liver Disease in Lung Transplant Recipients.
    Mallea J; Bolan C; Cortese C; Harnois D
    Liver Transpl; 2019 Aug; 25(8):1265-1275. PubMed ID: 31102574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cystic Fibrosis-related cirrhosis.
    Leung DH; Narkewicz MR
    J Cyst Fibros; 2017 Nov; 16 Suppl 2():S50-S61. PubMed ID: 28986027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Best practice guidance for the diagnosis and management of cystic fibrosis-associated liver disease.
    Debray D; Kelly D; Houwen R; Strandvik B; Colombo C
    J Cyst Fibros; 2011 Jun; 10 Suppl 2():S29-36. PubMed ID: 21658639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Multidisciplinary Approach to Pretransplant and Posttransplant Management of Cystic Fibrosis-Associated Liver Disease.
    Freeman AJ; Sellers ZM; Mazariegos G; Kelly A; Saiman L; Mallory G; Ling SC; Narkewicz MR; Leung DH
    Liver Transpl; 2019 Apr; 25(4):640-657. PubMed ID: 30697907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Barrier to using APRI and GPR as identifiers of cystic fibrosis liver disease.
    Sellers ZM
    J Cyst Fibros; 2021 May; 20(3):551. PubMed ID: 32747194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Liver disease, gastrointestinal complications, nutritional management and feeding disorders in pediatric cystic fibrosis].
    Debray D; Mas E; Munck A; Gérardin M; Clouzeau H
    Arch Pediatr; 2016 Dec; 23(12S):12S15-12S20. PubMed ID: 28231889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver disease in children with cystic fibrosis.
    Diwakar V; Pearson L; Beath S
    Paediatr Respir Rev; 2001 Dec; 2(4):340-9. PubMed ID: 12052306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic Manifestations of Cystic Fibrosis.
    Sakiani S; Kleiner DE; Heller T; Koh C
    Clin Liver Dis; 2019 May; 23(2):263-277. PubMed ID: 30947876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of liver disease in cystic fibrosis.
    Davison S
    Paediatr Respir Rev; 2018 Jun; 27():24-27. PubMed ID: 29933897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liver disease in cystic fibrosis.
    Flora KD; Benner KG
    Clin Liver Dis; 1998 Feb; 2(1):51-61. PubMed ID: 15560045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis, follow-up and treatment of cystic fibrosis-related liver disease.
    van de Peppel IP; Bertolini A; Jonker JW; Bodewes FAJA; Verkade HJ
    Curr Opin Pulm Med; 2017 Nov; 23(6):562-569. PubMed ID: 28837442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholangiocyte biology and cystic fibrosis liver disease.
    Feranchak AP; Sokol RJ
    Semin Liver Dis; 2001 Nov; 21(4):471-88. PubMed ID: 11745036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of a large cohort of cystic fibrosis patients with severe liver disease indicates lung function decline does not significantly differ from that of the general cystic fibrosis population.
    Polineni D; Piccorelli AV; Hannah WB; Dalrymple SN; Pace RG; Durie PR; Ling SC; Knowles MR; Stonebraker JR
    PLoS One; 2018; 13(10):e0205257. PubMed ID: 30307979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The natural history of cystic fibrosis liver disease a prospective cohort study.
    Rowland M; Drummond J; Connolly L; Daly E; McCormick PA; Bourke B; ;
    J Cyst Fibros; 2023 Nov; 22(6):1054-1061. PubMed ID: 37495468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term prospective study of the effect of ursodeoxycholic acid on cystic fibrosis-related liver disease.
    Nousia-Arvanitakis S; Fotoulaki M; Economou H; Xefteri M; Galli-Tsinopoulou A
    J Clin Gastroenterol; 2001 Apr; 32(4):324-8. PubMed ID: 11276276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.